243 related articles for article (PubMed ID: 29259858)
1.
Kollikowski AM; Kahles F; Kintsler S; Hamada S; Reith S; Knüchel R; Röcken C; Mottaghy FM; Marx N; Burgmaier M
Intractable Rare Dis Res; 2017 Nov; 6(4):291-294. PubMed ID: 29259858
[TBL] [Abstract][Full Text] [Related]
2. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of
Ross JC; Hutt DF; Burniston M; Page J; Steeden JA; Gillmore JD; Wechalekar AD; Hawkins PN; Fontana M
Amyloid; 2018 Sep; 25(3):203-210. PubMed ID: 30486686
[TBL] [Abstract][Full Text] [Related]
4. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
[TBL] [Abstract][Full Text] [Related]
5. The Utility of
Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P
Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403
[TBL] [Abstract][Full Text] [Related]
6. Native T1 mapping in transthyretin amyloidosis.
Fontana M; Banypersad SM; Treibel TA; Maestrini V; Sado DM; White SK; Pica S; Castelletti S; Piechnik SK; Robson MD; Gilbertson JA; Rowczenio D; Hutt DF; Lachmann HJ; Wechalekar AD; Whelan CJ; Gillmore JD; Hawkins PN; Moon JC
JACC Cardiovasc Imaging; 2014 Feb; 7(2):157-65. PubMed ID: 24412190
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Quantification of Myocardial Amyloid Deposits in Patients with Suspected Transthyretin-Related Amyloidosis (ATTR).
Wollenweber T; Rettl R; Kretschmer-Chott E; Rasul S; Kulterer O; Rainer E; Raidl M; Schaffarich MP; Matschitsch S; Stadler M; Traub-Weidinger T; Beiztke D; Loewe C; Duca F; Mascherbauer J; Bonderman D; Hacker M
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33120935
[TBL] [Abstract][Full Text] [Related]
8. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
[TBL] [Abstract][Full Text] [Related]
9. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
10. A case of cardiac amyloidosis incidentally detected by bone scintigraphy.
Tanaka H; Hosono M; Kanagaki M; Shimizu M; Matsubara N; Kawabata K; Miyamoto T; Itoi K
Asia Ocean J Nucl Med Biol; 2021; 9(1):71-75. PubMed ID: 33392354
[TBL] [Abstract][Full Text] [Related]
11. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.
Papantoniou V; Valsamaki P; Kastritis S; Tsiouris S; Delichas Z; Papantoniou Y; Tsiouma M; Athanasoulis T; Fotopoulos A; Dimopoulos MA
Hell J Nucl Med; 2015; 18 Suppl 1():42-50. PubMed ID: 26665211
[TBL] [Abstract][Full Text] [Related]
12. Pitfalls for the non-invasive diagnosis of wild-type transthyretin amyloid cardiomyopathy in a young adult: a case report.
Chang HC; Kuo L; Chung FP; Yu WC
Eur Heart J Case Rep; 2023 Jul; 7(7):ytad308. PubMed ID: 37501713
[TBL] [Abstract][Full Text] [Related]
13. A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant.
Ono R; Takahashi H; Sato T; Yamazaki T; Hori Y; Fukushima K
J Cardiol Cases; 2020 Nov; 22(5):221-225. PubMed ID: 33133314
[TBL] [Abstract][Full Text] [Related]
14. Illustrative review of cardiac amyloidosis by multimodality imaging.
Tanaka H
Heart Fail Rev; 2023 Jan; 28(1):113-122. PubMed ID: 35474404
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive risk stratification of patients with transthyretin amyloidosis.
Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
[TBL] [Abstract][Full Text] [Related]
16. Coexisting transthyretin and atrial natriuretic peptide amyloid on left atrium in transthyretin amyloid cardiomyopathy.
Kuyama N; Takashio S; Nakamura K; Nishigawa K; Hanatani S; Usuku H; Yamamoto E; Ueda M; Fukui T; Tsujita K
J Cardiol Cases; 2024 Jun; 29(6):261-264. PubMed ID: 38826764
[TBL] [Abstract][Full Text] [Related]
17. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.
Treglia G; Glaudemans AWJM; Bertagna F; Hazenberg BPC; Erba PA; Giubbini R; Ceriani L; Prior JO; Giovanella L; Slart RHJA
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1945-1955. PubMed ID: 29687207
[TBL] [Abstract][Full Text] [Related]
19. Description of a different quantification method for amyloid burden (DPDload) and validation of SPECT/CT in cardiac amyloidosis.
Mallón Araujo MDC; Abou Jokh Casas E; Abou Jokh Casas C; Aguade Bruix S; Ruibal Morell Á; Pubul Núñez V
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(3):171-177. PubMed ID: 36796676
[TBL] [Abstract][Full Text] [Related]
20. Quantitative SPECT/CT parameters of myocardial
Ben-Haim S; Chicheportiche A; Goshen E; Arad M; Smekhov M; Menezes LJ; Elliott PM; O'Mahoney E; Stern E; Yuzefovich B; Bomanji JB
EJNMMI Res; 2021 Sep; 11(1):86. PubMed ID: 34487268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
